209 related articles for article (PubMed ID: 38065446)
1. Targeted drug delivery systems for matrix metalloproteinase-responsive anoparticles in tumor cells: A review.
Guo F; Du Y; Wang Y; Wang M; Wang L; Yu N; Luo S; Wu F; Yang G
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128658. PubMed ID: 38065446
[TBL] [Abstract][Full Text] [Related]
2. A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy.
Zong L; Xu H; Zhang H; Tu Z; Zhang X; Wang S; Li M; Feng Y; Wang B; Li L; Xie X; He Z; Pu X
Int J Biol Macromol; 2024 Mar; 262(Pt 2):130043. PubMed ID: 38340921
[TBL] [Abstract][Full Text] [Related]
3. MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.
Yao Q; Kou L; Tu Y; Zhu L
Trends Pharmacol Sci; 2018 Aug; 39(8):766-781. PubMed ID: 30032745
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
5. A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy.
Bhattacharya S; Prajapati BG; Singh S
Crit Rev Oncol Hematol; 2023 May; 185():103961. PubMed ID: 36921781
[TBL] [Abstract][Full Text] [Related]
6. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
7. MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.
Kucharczyk K; Florczak A; Kaminska A; Guzniczak N; Sikorska A; Deptuch T; Dams-Kozlowska H
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132016. PubMed ID: 38697442
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation.
Zhang X; Wang X; Zhong W; Ren X; Sha X; Fang X
Int J Nanomedicine; 2016; 11():1643-61. PubMed ID: 27217744
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinase-Responsive Drug Delivery Systems.
Zhang C; Jiang G; Gao X
Bioconjug Chem; 2023 Aug; 34(8):1349-1365. PubMed ID: 37533285
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
11. [Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug].
Lu X; Guo X; Wan D; Pan J
Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1723-1731. PubMed ID: 33164451
[TBL] [Abstract][Full Text] [Related]
12. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
13. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-responsive nano-drug delivery system for combined antitumor therapy.
Guo F; Jiao Y; Du Y; Luo S; Hong W; Fu Q; Li A; Wang G; Yang G
Int J Biol Macromol; 2022 Nov; 220():1133-1145. PubMed ID: 35988724
[TBL] [Abstract][Full Text] [Related]
15. Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel.
Zhou K; Zhu Y; Chen X; Li L; Xu W
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111006. PubMed ID: 32993973
[TBL] [Abstract][Full Text] [Related]
16. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
17. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
Liu Y; Ding X; Li J; Luo Z; Hu Y; Liu J; Dai L; Zhou J; Hou C; Cai K
Nanotechnology; 2015 Apr; 26(14):145102. PubMed ID: 25789511
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.
Xiong J; Gao H
J Microencapsul; 2017 Aug; 34(5):440-453. PubMed ID: 28617063
[TBL] [Abstract][Full Text] [Related]
20. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
Chen Z; Wang X; Zhao N; Chen H; Guo G
Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
